Skin Toxicity Assessment of Silver Nanoparticles in a 3D Epidermal Model Compared to 2D Keratinocytes

References

• Crosera M, Bovenzi M, Maina G, et al. Nanoparticle dermal absorption and toxicity: a review of the literature. Int Arch Occup Environ Health. 2009;82(9):1043–1055. doi:10.1007/s00420-009-0458-x19705142
   PubMed Web of Science ®Google Scholar
• Augustine R, Kalarikkal N, Thomas S. Electrospun PCL membranes incorporated with biosynthesized silver nanoparticles as antibacterial wound dressings. Appl Nanosci. 2016;6(3):337–344. doi:10.1007/s13204-015-0439-1
   Web of Science ®Google Scholar
• Augustine R, Augustine A, Kalarikkal N, et al. Fabrication and characterization of biosilver nanoparticles loaded calcium pectinate nano-micro dual-porous antibacterial wound dressings. Prog Biomater. 2016;5(3–4):223–235. doi:10.1007/s40204-016-0060-827995588
   PubMed Web of Science ®Google Scholar
• Wijnhoven S, Peijnenburg W, Herberts C, et al. Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology. 2009;3(2):109–138. doi:10.1080/17435390902725914
   Web of Science ®Google Scholar
• AshaRani PV, Low Kah Mun G, Hande MP, et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009;3(2):279–290. doi:10.1021/nn800596w19236062
   PubMed Web of Science ®Google Scholar
• Shahbazzadeh D, Ahari H, Motalebi AA, et al. In vitro effect of Nanosilver toxicity on fibroblast and mesenchymal stem cell lines. Iran J Fish Sci. 2011;10(3):487–496. doi:10.1093/icesjms/fsr023
   Web of Science ®Google Scholar
• Kim S, Choi JE, Choi J, et al. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol in Vitro. 2009;23(6):1076–1084. doi:10.1016/j.tiv.2009.06.00119508889
   PubMed Web of Science ®Google Scholar
• Antony JJ, Sivalingam P, Chen B. Toxicological effects of silver nanoparticles. Environ Toxicol Pharmacol. 2015;40(3):729–732. doi:10.1016/j.etap.2015.09.00326425943
   PubMedGoogle Scholar
• Jones CF, Grainger DW. In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev. 2009;61(6):438–456. doi:10.1016/j.addr.2009.03.00519383522
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Meng H, et al. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. Acc Chem Res. 2013;46(3):607–621. doi:10.1021/ar300022h22676423
   PubMed Web of Science ®Google Scholar
• Johnston HJ, Hutchison G, Christensen FM, et al. A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 2010;40(4):328–346. doi:10.3109/1040844090345307420128631
   PubMed Web of Science ®Google Scholar
• Lee J, Cuddihy MJ, Kotov NA. Three-dimensional cell culture matrices: state of the art. Tissue Eng Part B Rev. 2008;14(1):61–86. doi:10.1089/teb.2007.015018454635
   PubMed Web of Science ®Google Scholar
• Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci. 2007;97(1):163–180. doi:10.1093/toxsci/kfm01817301066
   PubMed Web of Science ®Google Scholar
• Astashkina A, Mann B, Grainger DW. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol Ther. 2012;134(1):82–106. doi:10.1016/j.pharmthera.2012.01.00122252140
   PubMed Web of Science ®Google Scholar
• Dhawan A, Sharma V. Toxicity assessment of nanomaterials: methods and challenges. Anal Bioanal Chem. 2010;398(2):589–605. doi:10.1007/s00216-010-3996-x20652549
   PubMed Web of Science ®Google Scholar
• Fröhlich E. Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles. Artif Cells Nanomed Biotechnol. 2018;46(sup2):1091–1107. doi:10.1080/21691401.2018.147970929956556
   PubMed Web of Science ®Google Scholar
• Danilenko DM, Phillips GD, Diaz D. In vitro skin models and their predictability in defining normal and disease biology, pharmacology, and toxicity. Toxicol Pathol. 2016;44(4):555–563. doi:10.1177/019262331663207426940714
   PubMed Web of Science ®Google Scholar
• Huh D, Hamilton GA, Ingber DE. From 3D cell culture to organs-on-chips. Trends Cell Biol. 2011;21(12):745–754. doi:10.1016/j.tcb.2011.09.00522033488
   PubMed Web of Science ®Google Scholar
• Joris F, Manshian BB, Peynshaert K, et al. Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap. Chem Soc Rev. 2013;42(21):8339–8359. doi:10.1039/c3cs60145e23877583
   PubMed Web of Science ®Google Scholar
• Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell. 2007;130(4):601–610. doi:10.1016/j.cell.2007.08.00617719539
   PubMed Web of Science ®Google Scholar
• Drewitz M, Helbling M, Fried N, et al. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. Biotechnol J. 2011;6(12):1488–1496. doi:10.1002/biot.20110029022102438
   PubMed Web of Science ®Google Scholar
• Mueller D, Krämer L, Hoffmann E, et al. 3D organotypic HepaRG cultures as in vitro model for acute and repeated dose toxicity studies. Toxicol in Vitro. 2014;28(1):104–112. doi:10.1016/j.tiv.2013.06.02423850736
   PubMed Web of Science ®Google Scholar
• Lee J, Lilly GD, Doty RC, et al. In vitro toxicity testing of nanoparticles in 3D cell culture. Small. 2009;5(10):1213–1221. doi:10.1002/smll.20080178819263430
   PubMed Web of Science ®Google Scholar
• Huang K, Ma H, Liu J, et al. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano. 2012;6(5):4483–4493. doi:10.1021/nn301282m22540892
   PubMed Web of Science ®Google Scholar
• Luo Y, Wang C, Hossain M, et al. Three-dimensional microtissue assay for high-throughput cytotoxicity of nanoparticles. Anal Chem. 2012;84(15):6731–6738. doi:10.1021/ac301191j22747067
   PubMedGoogle Scholar
• Movia D, Prina-Mello A, Bazou D, et al. Screening the cytotoxicity of single-walled carbon nanotubes using novel 3D tissue-mimetic models. ACS Nano. 2011;5(11):9278–9290. doi:10.1021/nn203659m22017733
   PubMedGoogle Scholar
• Wills JW, Hondow N, Thomas AD, et al. Genetic toxicity assessment of engineered nanoparticles using a 3D in vitro skin model (EpiDerm™). Part Fibre Toxicol. 2016;13(1):50. doi:10.1186/s12989-016-0161-527613375
   PubMedGoogle Scholar
• Marambio-Jones C, Hoek E. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res. 2010;12(5):1531–1551. doi:10.1007/s11051-010-9900-y
   Web of Science ®Google Scholar
• Prabha RD, Kandasamy R, Sivaraman US, et al. Antibacterial nanosilver coated orthodontic bands with potential implications in dentistry. Indian J Med Res. 2016;144(4):580–586. doi:10.4103/0971-5916.20089528256467
   PubMedGoogle Scholar
• Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect. 2010;118(3):407–413. doi:10.1289/ehp.090139820064793
   PubMed Web of Science ®Google Scholar
• Hyun JS, Lee BS, Ryu HY, et al. Effects of repeated silver nanoparticles exposure on the histological structure and mucins of nasal respiratory mucosa in rats. Toxicol Lett. 2008;182(1–3):24–28. doi:10.1016/j.toxlet.2008.08.00318782608
   PubMed Web of Science ®Google Scholar
• Wu M, Guo H, Liu L, et al. Size-dependent cellular uptake and localization profiles of silver nanoparticles. Int J Nanomedicine. 2019;14:4247–4259. doi:10.2147/IJN.S20110731239678
   PubMed Web of Science ®Google Scholar
• Organization for Economic Cooperation and Development (OECD). Guidelines for the Testing of Chemicals. In vitro Skin Irritation: Reconstructed Human Epidermis Test Method. 2015.
   Google Scholar
• Ponec M, Weerheim A, Kempenaar J, et al. Lipid composition of cultured human keratinocytes in relation to their differentiation. J Lipid Res. 1988;29(7):949–961. doi:10.1080/03003930.2014.9300252457643
   PubMedGoogle Scholar
• Pruniéras M, Régnier M, Woodley D. Methods for cultivation of keratinocytes with an air-liquid interface. J Invest Dermatol. 1983;81(1 Suppl):28s–33s. doi:10.1111/1523-1747.ep125403246190962
   PubMed Web of Science ®Google Scholar
• Bell E, Ehrlich HP, Buttle DJ, et al. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science. 1981;211(4486):1052–1054. doi:10.1126/science.70081977008197
   PubMed Web of Science ®Google Scholar
• Tinois E, Tiollier J, Gaucherand M, et al. In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. Exp Cell Res. 1991;193(2):310–9.10. doi:10.16/0014-4827(91)90102-Z2004647
   PubMedGoogle Scholar
• Cannon CL, Neal PJ, Southee JA, et al. New epidermal model for dermal irritancy testing. Toxicol in vitro. 1994;8(4):889–891. doi:10.1016/0887-2333(94)90095-720693039
   PubMed Web of Science ®Google Scholar
• Rosdy M, Clauss LC. Terminal epidermal differentiation of human keratinocytes grown in chemically defined medium on inert filter substrates at the air-liquid interface. J Invest Dermatol. 1990;95(4):409–414. doi:10.1111/1523-1747.ep125555101698886
   PubMedGoogle Scholar
• Boyce S, Michel S, Reichert U, et al. Reconstructed skin from cultured human keratinocytes and fibroblasts on a collagen-glycosaminoglycan biopolymer substrate. Skin Pharmacol. 1990;3(2):136–143. doi:10.1159/0002108602127678
   PubMedGoogle Scholar
• Gibbs S, Vicanová J, Bouwstra J, et al. Culture of reconstructed epidermis in a defined medium at 33 degrees C shows a delayed epidermal maturation, prolonged lifespan and improved stratum corneum. Arch Dermatol Res. 1997;289(10):585–595. doi:10.1007/s0040300502449373718
   PubMedGoogle Scholar
• Ponec M, Weerheim A, Kempenaar J, et al. The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C. J Invest Dermatol. 1997;109(3):348–355. doi:10.1111/1523-1747.ep123360249284103
   PubMedGoogle Scholar
• Boelsma E, Gibbs S, Faller C, et al. Characterization and comparison of reconstructed skin models: morphological and immunohistochemical evaluation. Acta Derm Venereol. 2000;80(2):82–88. doi:10.1080/00015550030001304310877124
   PubMedGoogle Scholar
• Netzlaff F, Lehr CM, Wertz PW, et al. The human epidermis models EpiSkin, SkinEthic and EpiDerm: an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport. Eur J Pharm Biopharm. 2005;60(2):167–178. doi:10.1016/j.ejpb.2005.03.00415913972
   PubMed Web of Science ®Google Scholar
• Chomiczewska D, Kieć-Swierczyńska M, Krecisz B. Irritant contact dermatitis. Part II. Evaluation evaluation of skin irritation potential of chemicals. Med Pr. 2009;60(3):209–214. doi:10.1111/j.1548-1387.2009.01074.x19746889
   PubMedGoogle Scholar
• El Ghalbzouri A, Siamari R, Willemze R, et al. Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines. Toxicol in Vitro. 2008;22(5):1311–1320. doi:10.1016/j.tiv.2008.03.01218474418
   PubMedGoogle Scholar
• Murthy PB, Kishore AS, Surekha P. Assessment of in vitro skin irritation potential of nanoparticles: RHE model. Methods Mol Biol. 2012;926:219–234. doi:10.1007/978-1-62703-002-1_1622975968
   PubMedGoogle Scholar
• Portes P, Grandidier MH, Cohen C, et al. Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study. Toxicol in vitro. 2002;16(6):765–770. doi:10.1016/S0887-2333(02)00090-512423661
   PubMedGoogle Scholar
• Kandárová H, Liebsch M, Gerner I, et al. The EpiDerm test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests–an assessment of the performance of the optimised test. Altern Lab Anim. 2005;33(4):351–367. doi:10.1177/02611929050330040816185104
   PubMedGoogle Scholar
• Cotovio J, Grandidier MH, Portes P, et al. The in vitro skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process. Altern Lab Anim. 2005;33(4):329–349. doi:10.1016/S0960-894X(01)00566-216185103
   PubMedGoogle Scholar
• Kandárová H, Liebsch M, Schmidt E, et al. Assessment of the skin irritation potential of chemicals by using the SkinEthic reconstructed human epidermal model and the common skin irritation protocol evaluated in the ECVAM skin irritation validation study. Altern Lab Anim. 2006;34(4):393–406. doi:10.1016/S1355-0306(05)71625-716945007
   PubMedGoogle Scholar
• Lehmann SG, Gilbert B, Maffeis TG, et al. In vitro dermal safety assessment of silver nanowires after acute exposure: tissue vs. cell models. Nanomaterials. 2018;8(4). doi:10.3390/nano8040232
   Web of Science ®Google Scholar
• Larese FF, D’Agostin F, Crosera M, et al. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology. 2009;255(1–2):33–37. doi:10.1016/j.tox.2008.09.02518973786
   PubMed Web of Science ®Google Scholar
• Madl AK, Plummer LE, Carosino C, et al. Nanoparticles, lung injury, and the role of oxidant stress. Annu Rev Physiol. 2014;76:447–465. doi:10.1146/annurev-physiol-030212-18373524215442
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Mädler L, et al. Toxic potential of materials at the nanolevel. Science. 2006;311(5761):622–627. doi:10.1126/science.111439716456071
   PubMed Web of Science ®Google Scholar
• Xiao GG, Wang M, Li N, et al. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem. 2003;278(50):50781–50790. doi:10.1074/jbc.M30642320014522998
   PubMedGoogle Scholar
• Ayres JG, Borm P, Cassee FR, et al. Evaluating the toxicity of airborne particulate matter and nanoparticles by measuring oxidative stress potential–a workshop report and consensus statement. Inhal Toxicol. 2008;20(1):75–99. doi:10.1080/0895837070166551718236225
   PubMed Web of Science ®Google Scholar
• Tiwari DK, Jin T, Behari J. Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods. 2011;21(1):13–24. doi:10.3109/15376516.2010.52918421080782
   PubMed Web of Science ®Google Scholar
• Chairuangkitti P, Lawanprasert S, Roytrakul S, et al. Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol in vitro. 2013;27(1):330–338. doi:10.1016/j.tiv.2012.08.02122940466
   PubMed Web of Science ®Google Scholar
• Carlson C, Hussain SM, Schrand AM, et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008;112(43):13608–13619. doi:10.1021/jp712087m18831567
   PubMed Web of Science ®Google Scholar
• Dubey P, Matai I, Kumar SU, et al. Perturbation of cellular mechanistic system by silver nanoparticle toxicity: cytotoxic, genotoxic and epigenetic potentials. Adv Colloid Interface Sci. 2015;221:4–21. doi:10.1016/j.cis.2015.02.00725935324
   PubMed Web of Science ®Google Scholar
• Herzog F, Loza K, Balog S, et al. Mimicking exposures to acute and lifetime concentrations of inhaled silver nanoparticles by two different in vitro approaches. Beilstein J Nanotechnol. 2014;5:1357–1370. doi:10.3762/bjnano.5.14925247119
   PubMed Web of Science ®Google Scholar
• Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011;85(7):743–750. doi:10.1007/s00204-010-0545-520428844
   PubMed Web of Science ®Google Scholar
• Kawata K, Osawa M, Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol. 2009;43(15):6046–6051. doi:10.1021/es900754q19731716
   PubMed Web of Science ®Google Scholar
• Allen DG, Riviere JE, Monteiro-Riviere NA. Identification of early biomarkers of inflammation produced by keratinocytes exposed to jet fuels jet A, JP-8, and JP-8(100). J Biochem Mol Toxicol. 2000;14(5):231–237. doi:10.1002/1099-0461(2000)14:5<231::aid-jbt1>3.0.CO;2-K10969994
   PubMed Web of Science ®Google Scholar
• Allen DG, Riviere JE, Monteiro-Riviere NA. Cytokine induction as a measure of cutaneous toxicity in primary and immortalized porcine keratinocytes exposed to jet fuels, and their relationship to normal human epidermal keratinocytes. Toxicol Lett. 2001;119(3):209–217. doi:10.1016/S0378-4274(00)00316-711246174
   PubMedGoogle Scholar
• Gröne A. Keratinocytes and cytokines. Vet Immunol Immunopathol. 2002;88(1–2):1–12. doi:10.1016/s0165-2427(02)00136-812088639
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Baynes RE, Riviere JE. Pyridostigmine bromide modulates topical irritant-induced cytokine release from human epidermal keratinocytes and isolated perfused porcine skin. Toxicology. 2003;183(1–3):15–28. doi:10.1016/S0300-483X(02)00421-312504339
   PubMedGoogle Scholar
• Park EJ, Yi J, Kim Y, et al. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol in Vitro. 2010;24(3):872–878. doi:10.1016/j.tiv.2009.12.00119969064
   PubMed Web of Science ®Google Scholar
• Foldbjerg R, Olesen P, Hougaard M, et al. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett. 2009;190(2):156–162. doi:10.1016/j.toxlet.2009.07.00919607894
   PubMed Web of Science ®Google Scholar
• Shin SH, Ye MK, Kim HS, et al. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol. 2007;7(13):1813–1818. doi:10.1016/j.intimp.2007.08.02517996693
   PubMed Web of Science ®Google Scholar
• Park S, Lee YK, Jung M, et al. Cellular toxicity of various inhalable metal nanoparticles on human alveolar epithelial cells. Inhal Toxicol. 2007;19(Suppl 1):59–65. doi:10.1080/0895837070149328217886052
   PubMed Web of Science ®Google Scholar
• Asharani P, Sethu S, Lim HK, et al. Differential regulation of intracellular factors mediating cell cycle, DNA repair and inflammation following exposure to silver nanoparticles in human cells. Genome Integr. 2012;3(1):2. doi:10.1186/2041-9414-3-222321936
   PubMedGoogle Scholar
• Park EJ, Bae E, Yi J, et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol. 2010;30(2):162–168. doi:10.1016/j.etap.2010.05.00421787647
   PubMed Web of Science ®Google Scholar
• Nadworny PL, Landry BK, Wang J, et al. Does nanocrystalline silver have a transferable effect? Wound Repair Regen. 2010;18(2):254–265. doi:10.1111/j.1524-475X.2010.00579.x20409150
   PubMedGoogle Scholar